Published in Transplant Proc on October 01, 2009
Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. PLoS One (2013) 0.88
Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma. Gut Liver (2016) 0.87
A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years. HPB (Oxford) (2012) 0.81
Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials. Hepatol Int (2014) 0.78
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Liver transplantation in Eastern Europe. Liver Transpl (2000) 1.39
Review and prospects of magnonic crystals and devices with reprogrammable band structure. J Phys Condens Matter (2014) 1.36
Magnonic band engineering by intrinsic and extrinsic mirror symmetry breaking in antidot spin-wave waveguides. Sci Rep (2013) 1.20
Evidence against the exon theory of genes derived from the triose-phosphate isomerase gene. Proc Natl Acad Sci U S A (1995) 1.06
A human putative Suv3-like RNA helicase is conserved between Rhodobacter and all eukaryotes. Acta Biochim Pol (1999) 1.01
Implications of overweight in gastric cancer: A multicenter study in a Western patient population. Eur J Surg Oncol (2010) 1.00
Function of the ovaries in female kidney transplant recipients. Transplant Proc (2006) 0.99
Diagnosis and treatment of sigmoidal endometriosis--a case report. Med Sci Monit (2001) 0.98
Forbidden band gaps in the spin-wave spectrum of a two-dimensional bicomponent magnonic crystal. Phys Rev Lett (2012) 0.96
Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology (2010) 0.96
Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol (2007) 0.95
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens (2007) 0.95
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol (2010) 0.94
Erratic evolution of glycerol-3-phosphate dehydrogenase in Drosophila, Chymomyza, and Ceratitis. J Mol Evol (1997) 0.92
The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. Transplant Proc (2007) 0.92
Trichosporon asahii as a prospective pathogen in solid organ transplant recipients. Mycoses (2008) 0.90
Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression. Transplant Proc (2006) 0.89
Machine perfusion preservation improves renal allograft survival. Am J Transplant (2007) 0.88
Treatment of early hepatic artery thrombosis after liver transplantation. Transplant Proc (2011) 0.88
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Aliment Pharmacol Ther (2010) 0.88
Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med (2010) 0.87
Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc (2002) 0.87
Choice of transplantation techniques and indications for liver transplantation in polycystic liver disease in patients with no signs of end-stage liver disease. Transplant Proc (2008) 0.87
Diagnostic value of different serological tests for tuberculosis in Poland. J Physiol Pharmacol (2004) 0.86
Investigations of morphological structure of acupuncture points and meridians. J Tradit Chin Med (1985) 0.86
Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery. Transplant Proc (2006) 0.85
Urinary tract infections in the early posttransplant period after kidney transplantation: etiologic agents and their susceptibility. Transplant Proc (2011) 0.85
Correlation between selected prognostic factors and postoperative course in liver transplant recipients. Transplant Proc (2009) 0.84
Orthotopic liver transplantation for cholestatic diseases. Hepatogastroenterology (2010) 0.84
Quantitative gene expression of TGF-beta1, TNF-alpha, IL-1beta, and IL-6 in the renal artery wall of chronically rejected human renal allografts. Transplant Proc (2002) 0.84
Vascular complications related to liver transplantation. Transplant Proc (2000) 0.84
Rehabilitation and 6-minute walk test after liver transplantation. Transplant Proc (2011) 0.84
A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients. Transplant Proc (2011) 0.83
Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report. Transplant Proc (2006) 0.83
Patient with liver epithelioid hemangioendothelioma treated by transplantation: 3 years' observation. Transplant Proc (2006) 0.83
TIPS: a therapy to prevent variceal rebleeding in patients listed for liver transplantation. Transplant Proc (2002) 0.83
Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience. Transplant Proc (2006) 0.83
Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Transplant Proc (2006) 0.83
Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc (2009) 0.83
Urinary tract infections in the early posttransplant period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc (2011) 0.82
Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity. Transplant Proc (2007) 0.82
Effect of chronic therapy with proteolytic enzymes on hypertension-induced renal injury in the rat model of Goldblatt hypertension. Am J Nephrol (1998) 0.82
Biliary tract complications following liver transplantation. Transplant Proc (2003) 0.82
Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model. Nephrol Dial Transplant (1996) 0.82
Serum concentration of vitamin D and parathyroid hormone after living kidney donation. Transplant Proc (2009) 0.82
Tuberculosis in patients after renal transplantation remains still a clinical problem. Transplant Proc (2002) 0.82
The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc (2006) 0.81
Low-dose hormonal contraception after liver transplantation. Transplant Proc (2007) 0.81
Assessment of early biliary complications after orthotopic liver transplantation and their relationship to the technique of biliary reconstruction. Transplant Proc (2006) 0.81
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. Clin Transpl (2007) 0.81
Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy. Res Exp Med (Berl) (2000) 0.81
Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc (2009) 0.81
High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods. Transplant Proc (2006) 0.81
Fever, human herpesvirus-6 (HHV-6) seroconversion, and acute rejection episodes as a function of the initial seroprevalence for HHV-6 in renal transplant recipients. Transplant Proc (2006) 0.81
Comparison of 1-year patient and graft survival rates between preemptive and dialysed simultaneous pancreas and kidney transplant recipients. Transplant Proc (2006) 0.80
Strong association between fibronectin accumulation and lowered cathepsin B activity in glomeruli of diabetic rats. J Physiol Pharmacol (2012) 0.80
Pregnancy outcomes among female recipients after liver transplantation: further experience. Transplant Proc (2011) 0.80
Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc (2003) 0.80
Liver regeneration in 120 consecutive living-related liver donors. Transplant Proc (2009) 0.80
Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis. Kidney Blood Press Res (1999) 0.80
Cardiovascular risk estimates and risk factors in renal transplant recipients. Transplant Proc (2005) 0.80
Safety and efficacy of hormonal therapy in menopausal kidney-allograft recipients. Transplant Proc (2006) 0.80
Early hyperglycemia after allogenic kidney transplantation. Ann Transplant (2007) 0.80
Dysphagia and retrosternal pain related to a round plastic foreign body impacted in the esophageal wall for over 20 years. Endoscopy (2008) 0.80
Biliary complications in relation to the technique of biliary reconstruction in adult liver transplant recipients. Transplant Proc (2007) 0.80
Liver transplantation in patients with hepatic failure. Transplant Proc (2002) 0.79
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun (1998) 0.79
High-resolution 1H nuclear magnetic resonance spectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant Proc (2003) 0.79
High rate of endometrial hyperplasia in renal transplanted women. Transplant Proc (2006) 0.79
Dose-dependent stimulation/inhibition effects of cyclosporin A on lysosomal cathepsin activities in cultured proximal tubule cells. Res Exp Med (Berl) (1995) 0.79
Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction. Age (Dordr) (2013) 0.79
Bacteria isolated from bile samples of liver recipients in the early period after transplantation: epidemiology and susceptibility of the bacterial strains. Transplant Proc (2007) 0.79
Biliary complications following liver transplantation. Transplant Proc (2000) 0.79
Resection of the liver in a metastatic disease caused by renal carcinoma. Mater Med Pol (1995) 0.79
Vascular complications after liver transplantation. Transplant Proc (2003) 0.79
Tremor associated with focal and segmental dystonia. Neurol Neurochir Pol (2013) 0.79
Arterial hypertension in liver transplant recipients. Transplant Proc (2011) 0.79
Inflammatory cytokines gene expression in bone tissue from patients with chronic rhinosinusitis- a preliminary study. Rhinology (2010) 0.79
Efficacy of antibiotic penetration into pancreatic necrosis. HPB (Oxford) (2006) 0.79
Increased mRNA expression of transforming growth factor beta in the arterial wall of chronically rejected renal allografts in humans. Transplant Proc (2006) 0.78